Nanotransfer
Developing the next generation delivery system for gene therapies
Developing the next generation delivery system for gene therapies
Nanotransfer is a biotechnology startup based in Argentina, founded in 2021. The company's slogan "Developing the next generation delivery system for gene therapies" encapsulates its goal to revolutionize gene therapies through the development of an innovative gene delivery system. In December 2021, Nanotransfer secured a significant $200.00K Pre Seed Round investment from GRIDX, demonstrating notable interest and support from investors in the biotechnology and healthcare industries. With a promising focus on cutting-edge gene delivery technology, Nanotransfer has potential to make a substantial impact in the field of gene therapies.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $200.00K | 1 |
|
25 Dec 2021 |
No recent news or press coverage available for Nanotransfer.
We care about your data, and we'd love to use cookies make your experience better.
